KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Payables (2016 - 2025)

Elevance Health (ELV) has disclosed Payables for 17 consecutive years, with $7.5 billion as the latest value for Q4 2025.

  • Quarterly Payables rose 2.47% to $7.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 billion through Dec 2025, up 2.47% year-over-year, with the annual reading at $7.5 billion for FY2025, 2.47% up from the prior year.
  • Payables for Q4 2025 was $7.5 billion at Elevance Health, up from $6.3 billion in the prior quarter.
  • The five-year high for Payables was $7.6 billion in Q2 2025, with the low at $5.1 billion in Q1 2023.
  • Average Payables over 5 years is $6.2 billion, with a median of $6.0 billion recorded in 2022.
  • The sharpest move saw Payables dropped 14.78% in 2022, then soared 40.77% in 2024.
  • Over 5 years, Payables stood at $5.2 billion in 2021, then rose by 11.95% to $5.9 billion in 2022, then increased by 21.51% to $7.1 billion in 2023, then grew by 2.2% to $7.3 billion in 2024, then rose by 2.47% to $7.5 billion in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $7.5 billion, $6.3 billion, and $7.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.